Kai Han
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Cancer-related gene regulation
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 6
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 3
- RNA Research and Splicing 3
- Co-authors
- Dan Xie (11 shared papers)Xin‐Yuan Guan (4 shared papers)Rui‐Hua Xu (4 shared papers)Feng‐Wei Wang (8 shared papers)Zhizhong Pan (14 shared papers)Jiaxing Zhang (2 shared papers)Rixin Chen (4 shared papers)Jiewei Chen (6 shared papers)
- Journals
- Molecular Cancer (3 papers)Cancer Letters (2 papers)Journal of the National Comprehensive Cancer Network (2 papers)Nature Communications (2 papers)Oncogene (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Kai Han
44 papers receiving 1.5k citations
Kai Han's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 672
- Molecular Biology 1.0k
- Pathology and Forensic Medicine 106
- Oncology 136
- Developmental Neuroscience 19
Countries citing papers authored by Kai Han
This map shows the geographic impact of Kai Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Han more than expected).
Fields of papers citing papers by Kai Han
This network shows the impact of papers produced by Kai Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Han. The network helps show where Kai Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis Hit paper breakdown → | 2019 | 548 |
| 2 | 2020 | 136 | |
| 3 | 2018 | 131 | |
| 4 | 2022 | 113 | |
| 5 | 1994 | 69 | |
| 6 | 2021 | 44 | |
| 7 | 2022 | 39 | |
| 8 | 2022 | 28 | |
| 9 | 2023 | 28 | |
| 10 | 2024 | 26 | |
| 11 | 2022 | 22 | |
| 12 | 2020 | 22 | |
| 13 | 2022 | 20 | |
| 14 | 2022 | 19 | |
| 15 | 2024 | 17 | |
| 16 | 2021 | 15 | |
| 17 | 2024 | 14 | |
| 18 | 2020 | 14 | |
| 19 | 2022 | 13 | |
| 20 | 2022 | 13 |
About Kai Han
Kai Han is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology and Insect Science, having authored 46 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (6 papers), Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers), Insect and Arachnid Ecology and Behavior (4 papers), Insect and Pesticide Research (4 papers), Plant and animal studies (4 papers), Ubiquitin and proteasome pathways (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Cancer Research (672 citations), Molecular Biology (1.0k citations), Pathology and Forensic Medicine (106 citations), Oncology (136 citations) and Developmental Neuroscience (19 citations). Kai Han has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Dan Xie, Xin‐Yuan Guan, Rui‐Hua Xu, Feng‐Wei Wang, Zhizhong Pan, Jiaxing Zhang, Rixin Chen, Jiewei Chen, Feng Wang and Olivier Déas. Their work appears in journals such as Molecular Cancer, Cancer Letters, Journal of the National Comprehensive Cancer Network, Nature Communications and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.